An analysis released Friday by Democrats on the congressional Joint Economic Committee details how US President Donald Trump loaded up on shares of major pharmaceutical companies last year as his administration and Republican allies enacted policies that benefited the industry — at the expense seniors and other patients. The JEC analysis estimates that Trump increased his stock holdings in…
From Truthout via This RSS Feed.
You must log in or # to comment.


